Kestra Medical Technologies, Ltd. (KMTS)

Revenue by Product

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
Wearable Cardioverter Defibrillator	59.82M
Wearable Cardioverter Defibrillator Growth	115.05%

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022
United States	59.82M
United States Growth	115.05%